fbpx

Biotin fails to help MS in latest trial

Biotin fails to help MS in latest trial Published: 02 November 2020 A recent phase III trial has found that high-dose pharmaceutical-grade biotin (MD1003) does not improve disability or walking speed in people with progressive multiple sclerosis (MS).  This outcome disappointed researchers because an earlier trial had found that biotin,
Read More

Cancer drug rebuilds myelin in humans with MS

Cancer drug rebuilds myelin in humans with MS Published: 29 September 2020 A recent clinical trial of a cancer drug showed it repaired the myelin sheath that multiple sclerosis (MS) attacks, but the findings are bittersweet as the drug’s side effects are too serious for it to be used as
Read More

Fatigue most impactful symptom in MS

Fatigue most impactful symptom in MS Published: 22 September 2020 According to a recent survey based in the US, fatigue is the symptom that impacts daily functioning the most in people living with multiple sclerosis (MS). The symptom is more severe in people who have relapse, depression, pain and sleep
Read More

Asthma drug helps regenerate myelin

Asthma drug helps regenerate myelin Published: 04 September 2020 A new study on mice has found a drug called theophylline, which is used to treat respiratory diseases helps regenerate myelin. In multiple sclerosis (MS), the immune system attacks and damages the myelin sheath which protects the nerves.  Researchers at Johannes
Read More

Cashew nut shell compound shows promise in mouse study

Another gCashew nut shell compound shows promise in mouse study Published: 24 August 2020 A compound found in cashew nuts shell called anacardic acid has been found to promote myelin repair and lessen neuronal damage and disability in a study on mice.  A research team from Vanderbilt University Medical Center
Read More

DMT does not increase risk of severe COVID-19

DMT does not increase risk of severe COVID-19 Published: 11 August 2020 Data from France has shown that for people with multiple sclerosis (MS), high scores on the expanded disability severity scale (EDSS), age, and obesity were linked as risk factors to more severe COVID-19 infections, but use of disease-modifying
Read More

MS increases vascular mortality risk

MS increases vascular mortality risk Published: 28 May 2020 New research has found that having multiple sclerosis (MS) is associated with an increased risk of acute coronary syndrome (ACS), stroke, and death, and the findings cannot be explained by traditional risk factors.  Scientists found that participants with MS had a
Read More

New technique to detect early-stage MS

New technique to detect early-stage MSPublished: 30 April 2020 Scientists have developed a new technique to diagnose early-stage multiple sclerosis (MS) and distinguish it from a similar autoimmune condition called neuromyelitis optica.  Brazilian researchers used a nanobiosensor, which was originally created to detect pollutants like herbicides and heavy metals, and
Read More

Early MS cognitive impairment not linked with ethnicity

Early MS cognitive impairment not linked with ethnicity Published: 09 April 2020 A new study has found that ethnicity doesn’t appear to have any influence on the severity of cognitive impairment in people in the early stages of multiple sclerosis (MS).   Researchers already know that changes in cognitive function during
Read More

Cognitive impairment worsens during relapse

Cognitive impairment worsens during relapse Published: 10 March 2020 A new study has found that people who experience a relapse from multiple sclerosis (MS) tend to see a decline in cognitive test scores, and sometimes don’t experience a full recovery.  A team of scientists from the University of Buffalo looked
Read More